Year |
Citation |
Score |
2005 |
Fruchtman S, Simmons JG, Michaylira CZ, Miller ME, Greenhalgh CJ, Ney DM, Lund PK. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 289: G342-50. PMID 15831713 DOI: 10.1152/Ajpgi.00413.2004 |
0.615 |
|
2004 |
Miller ME, Michaylira CZ, Simmons JG, Ney DM, Dahly EM, Heath JK, Lund PK. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology. 127: 570-81. PMID 15300589 DOI: 10.1053/J.Gastro.2004.05.016 |
0.617 |
|
2004 |
Dahly EM, Miller ME, Lund PK, Ney DM. Postreceptor resistance to exogenous growth hormone exists in the jejunal mucosa of parenterally fed rats. The Journal of Nutrition. 134: 530-7. PMID 14988442 DOI: 10.1093/Jn/134.3.530 |
0.533 |
|
2002 |
Greenhalgh CJ, Miller ME, Hilton DJ, Lund PK. Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease. Gastroenterology. 123: 2064-81. PMID 12454862 DOI: 10.1053/Gast.2002.37068 |
0.391 |
|
2001 |
Miller M, Simmons J, Ney D, Whitehead R, Lund PK. Suppressor of cytokine signaling-2 (SOCS-2) may limit GH-induced intestinal mucosal collagen synthesis Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)83480-4 |
0.437 |
|
2000 |
Miller ME, Goebel HN, Williams KL, Keku TO, Pucilowska JB, Sartor RB, Lund PK. Suppressor of cytokine signaling-3 (SOCS-3) mRNA is preferentially induced during experimental enterocolitis, ulcerative colitis and Crohn's disease Regulatory Peptides. 94: 67. DOI: 10.1016/S0167-0115(00)80135-4 |
0.484 |
|
2000 |
Williams KL, Miller ME, DaCosta CM, Dieleman LA, Sartor RB, Lund PK. Evidence for inhibition of cytokine action by growth hormone during recovery from experimental enterocolitis Regulatory Peptides. 94: 20. DOI: 10.1016/S0167-0115(00)80040-3 |
0.552 |
|
Show low-probability matches. |